Bionano Genomics, Inc. (BMV:BNGO)
Mexico flag Mexico · Delayed Price · Currency is MXN
57.00
0.00 (0.00%)
At close: Aug 13, 2025, 2:00 PM CST

Bionano Genomics Company Description

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules.

In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for analysis and interpretation of genomic data from microarray and sequencing data for cytogenetics and molecular genetics.

Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing.

Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Bionano Genomics, Inc.
Country United States
Founded 2003
Industry Surgical and Medical Instruments and Apparatus
Employees 100
CEO Robert Holmlin

Contact Details

Address:
9540 Towne Centre Drive
San Diego, Delaware 92121
United States
Phone 858 888 7600
Website bionano.com

Stock Details

Ticker Symbol BNGO
Exchange Mexican Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 3841

Key Executives

Name Position
Robert Holmlin Chief Executive Officer
Robert Holmlin Chief Financial Officer
Mark Oldakowski Chief Operating Officer